GH1 and pituitary gland adenoma: Testing its effects in vitro and in vivo TBR-065 showed a higher potency and efficacy in suppressing GH secretion compared with both octreotide and cabergoline (alone or in combination) in primary human pituitary adenoma cells from patients with partially octreotide-responsive acromegaly [142].